Valeo Pharma Inc. VPHIF
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.1181 Day range 0.1181
0.0001 52-week range 0.1181
- YTD
- 0.00%
- 1 year
- -66.67%
- Open
- 0.1181
- Prev close
- 0.0001
- Mkt cap
- 9.87K
- Vol
- 4.50K
- Avg vol
- 0
- EPS
- -0.27
- P/E
- 0.00
More statistics
- Low
- 0.1181
- High
- 0.1181
Financial health
Altman Z-Score
-6.72 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.5×
FY 2016 5y median -4.2× FY 2023
P/S 0.2×
FY 2016 5y median 4.3× FY 2023
P/B -0.3×
FY 2016 5y median -0.3× FY 2023
P/FCF -0.6×
FY 2016 5y median -3.7× FY 2023
EV/EBITDA -6.2×
FY 2016 5y median -6.2× FY 2023
EV/Sales 1.3×
FY 2016 5y median 4.8× FY 2023
FCF Yield -169.5%
FY 2016 5y median -26.8% FY 2023
Profitability
Gross Margin 24.3%
FY 2016 5y median 22.6% FY 2023
Operating Margin -32.0%
FY 2016 5y median -58.1% FY 2023
Net Margin -51.6%
FY 2016 5y median -63.7% FY 2023
ROE 68.9%
FY 2016 5y median 68.9% FY 2023
ROIC -67.3%
FY 2016 5y median -67.3% FY 2023
ROA -67.5%
FY 2016 5y median -62.3% FY 2023
Growth (YoY)
Revenue 94.3%
FY 2016 FY 2023
Operating Income 12.1%
FY 2016 FY 2023
EPS (diluted) 0.0%
FY 2016 FY 2023
Free Cash Flow 40.0%
FY 2016 FY 2023
Financial Health
Current Ratio 1.2×
FY 2016 5y median 1.2× FY 2023
Quick Ratio 0.7×
FY 2016 5y median 0.7× FY 2023
Debt / Equity -1.6×
FY 2016 5y median -1.6× FY 2023
Net Debt / EBITDA -5.1×
FY 2016 5y median -0.5× FY 2023
Interest Coverage -1.2×
FY 2016 5y median -7.3× FY 2023
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-10-31